Vergoeding 2015-2019 voor ATC-subgroep J05AX : Overige antivirale middelen
- Raming voor de totale Zvw-populatie
| 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|
| J05AX07 Enfuvirtide (Fuzeon ®) | 892 | 3.289 | . | . | . |
| J05AX08 Raltegravir (Isentress ®) | 8.333.800 | 6.668.200 | 5.478.400 | 5.432.600 | 5.017.200 |
| J05AX09 Maraviroc (Celsentri ®) | 1.037.100 | 965.200 | 839.930 | 766.600 | 739.300 |
| J05AX12 Dolutegravir (Tivicay ®) | 6.356.400 | 10.339.000 | 12.187.500 | 14.405.900 | 15.837.200 |
| J05AX16 Overige antivirale middelen | . | 2.089 | 6.268 | . | . |
| J05AX18 Letermovir (Prevymis ®) | . | . | . | . | 381.920 |
| J05AX67 Overige antivirale middelen | . | 71.883 | 84.543 | . | . |
| Totaal | 15.728.192 | 18.049.661 | 18.596.641 | 20.605.100 | 21.975.620 |